Patients access care through secure messaging and video consultations without travel, waiting rooms, or scheduling conflicts that might discourage regular follow-up in traditional settings
Burn Stubborn Fat, Anti-aging, Muscle retention Injections are typically self-administered with a small, easy-to-use syringe
Canada part of a multi-country global rollout Novo Nordisk's Canadian patent expired in January 2026, and generic semaglutide became legal in India on March 23, 2026
Medication dosing also plays a role
23, Novo executives said CagriSema still has the potential to deliver the highest weight loss of any drug on the market after its expected approval by the Food and Drug Administration by the end of 2026 and launch in 2027
Verified customer Superb 10 months in and lost a considerable fraction of my initial weight absolutely worth it Vivian S